Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05450744 |
| Title | 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (IPAX-2) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Telix International Pty Ltd |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD | AUT | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Gold Coast University Hospital | Gold Coast | Queensland | 4215 | Australia | Details | |
| Royal Adelaide Hospital | Adelaide | South Australia | Australia | Details | ||
| Olivia Newton John Cancer Research Institute/Austin Health | Melbourne | Victoria | Australia | Details | ||
| Institut für Nuklearmedizin und Endokrinologie | Linz | Austria | Details | |||
| UNMC Utrecht | Utrecht | 3051 | Netherlands | Details |